Nephro Care India
Nephro Care India Share Price Chart
Nephro Care India last traded at ₹83.80 (2026-10-13). Over the past month the stock moved -8.4%, three months the stock moved +4.0%, year the stock moved -39.3%. Its closing range over 52 weeks is ₹52.30 – ₹148.00, with the latest close 43.4% below the high.
Closing prices up to 2026-10-13.
About Nephro Care India
Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes in the treatment of kidney- related diseases[1]
Business Overview:[1][2] NCIL provides comprehensive medical services for renal patients as a one-stop treatment center in Kolkata. It offers clinical and lifestyle solutions for renal insufficiency, covering lifestyle, physiological, and spiritual wellness. The company specializes in non-invasive services.
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 29.19 | 3.62 | 12.40 | 1.61 | 0.98 |
| Mar 2026 | 26.75 | 2.02 | 7.55 | 1.00 | 0.61 |
| Dec 2025 | 22.66 | 1.91 | 8.43 | 0.42 | 0.25 |
| Jun 2025 | 17.33 | 0.60 | 3.46 | -0.65 | -0.39 |
Annual Financials
In the latest year (Mar 2026), Nephro Care India reported sales of ₹88.73 crore (+92.8%) and net profit of ₹3.37 crore (-7.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 88.73 | 8.32 | 9.38 | 3.37 | 2.04 |
| Mar 2025 | 46.03 | 5.87 | 12.75 | 3.64 | 2.21 |
| Mar 2024 | 27.23 | 6.47 | 23.76 | 4.41 | 3.71 |
| Mar 2023 | 17.09 | 3.43 | 20.07 | 2.37 | 47.40 |
| Mar 2022 | 3.42 | 0.14 | 4.09 | -0.01 | -0.20 |
| Mar 2021 | 1.82 | 0.15 | 8.24 | 0.09 | 90.00 |
| Mar 2020 | 0.54 | 0.02 | 3.70 | -0.01 | -10.00 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +237.0% | +87.9% | +399.7% | +59.3% | +69.0% | +92.8% |
| Operating profit growth | +650.0% | -6.7% | +2350.0% | +88.6% | -9.3% | +41.7% |
| Net profit growth | – | -111.1% | – | +86.1% | -17.5% | -7.4% |
| EPS growth | – | -100.2% | – | -92.2% | -40.4% | -7.7% |
| OPM % | 8.2% | 4.1% | 20.1% | 23.8% | 12.8% | 9.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Nephro Care India.
Get Free AI Stock Analysis FREE →Latest News
-
'Buy' Nephrocare Health Services for 16% upside, says ICICI Securities; check share price target
-
Nephrocare Health to acquire Kazakhstan-based Dialysis Center Almaty for Rs 11.6 crore - Business Standard
-
Price Band Hitters on August 19, 2026: Nephrocare Gains 4.94%, Dharan Infra-Epc Remains Flat
-
Nephrocare Health Services consolidated net profit rises 34.89% in the June 2026 quarter - Business Standard
-
Nephrocare Health Services consolidated net profit rises 34.89% in the June 2026 quarter - Business Standard
-
Nephrocare Health Services schedules 17th AGM for August 12, 2026 - scanx.trade
-
Nephrocare Health Services Ltd Upgraded to Hold on Technical and Financial Improvements
-
Nephrocare Health Services Ltd Shows Renewed Momentum with Technical Upgrades
-
Nephrocare Health Services Ltd Hits All-Time High of Rs 662 as Momentum Builds Across Timeframes
-
Broad-Based Technical Strength Lifts Nephrocare Health Services Ltd to 52-Week High of Rs 663
Frequently Asked Questions
What is the share price of Nephro Care India today?
Nephro Care India shares were last quoted at ₹83.80 (-0.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Nephro Care India?
Nephro Care India has a price-to-earnings (P/E) ratio of 27.43 and a price-to-book (P/B) ratio of 2.64. The industry P/E is 101.02.
What is the 52-week high and low of Nephro Care India?
The 52-week high of Nephro Care India is ₹156.35 and the 52-week low is ₹50.05.
What is the market cap of Nephro Care India?
The market capitalisation of Nephro Care India is about ₹154.23 crore.
Is Nephro Care India a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Nephro Care India has a 3-year ROE of 11.00%, 3-year profit growth of 12.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Nephro Care India?
Promoters hold about 61.71% of Nephro Care India.
Which sector does Nephro Care India belong to?
Nephro Care India belongs to the Hospital & Healthcare Services sector.
Other Hospital & Healthcare Services stocks
- Apollo Hospitals Enterprises
- Max Healthcare Institute
- Manipal Health Enterprises
- Aster DM Quality Care
- Fortis Healthcare
- Global Health
- Narayana Hrudayalaya
- Krishna Institute of Medical Sciences
All Hospital & Healthcare Services stocks · Browse all stocks A–Z